Tinengotinib
TransThera Sciences (Nanjing)
['solid tumor']
 s dr. sanjay goel &amp; colleagues present preliminary safety &amp; efficacy of tinengotinib tablets as monotherapy and combination therapy in advanced solid tumors: a phase ib/ii clinical trial. #asco23 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.